Literature DB >> 8535153

Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli.

G M Birch1, T Black, S K Malcolm, M T Lai, R E Zimmerman, S R Jaskunas.   

Abstract

A gene encoding the human rhinovirus 14 (HRV14) sequence for expression of the viral polypeptide protein delta 3ABC was inserted into a plasmid driven by the heat-inducible bacteriophage lambda PL promoter. The coding sequence was also inserted into a pET vector for expression in the T7 system to produce 13C, 15N-labeled protein. The expressed HRV14 3C protease (3Cpro) autocatalytically cleaved itself from the polyprotein delta 3ABC, and the mature HRV14 3Cpro partitioned predominantly, in the case of the T7 system, in the insoluble fraction and exclusively, in the case of the PL system, in the insoluble fraction. The insoluble HRV14 3Cpro was solubilized in urea and purified using anion- and cation-exchange chromatography. The protease was refolded/activated and further purified using a size-exclusion column. HRV14 3Cpro was purified to > 90% homogeneity as shown by SDS-PAGE and to 95% by HPLC. A continuous fluorescence assay was developed which utilized an intramolecularly quenched 9-amino-acid substrate. The substrate anthranilic acid (Anc)-Thr-Leu-Phe-Gln-Gly-Pro-Val-(p-NO2)-Phe-Lys mimicked the natural 2C/3A cleavage site (Thr-Leu-Phe-Gln-Gly-Pro-Val-Tyr-Phe) using an N-terminal anthranilic acid donor group on one side of the scissile bond (Gln/Gly) and a p-NO2-Phe acceptor group at the P4 position. Measured by the fluorescence assay, HRV14 3Cpro had a Km of 300 microM for the substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535153     DOI: 10.1006/prep.1995.1080

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Genetic circuit performance under conditions relevant for industrial bioreactors.

Authors:  Felix Moser; Nicolette J Broers; Sybe Hartmans; Alvin Tamsir; Richard Kerkman; Johannes A Roubos; Roel Bovenberg; Christopher A Voigt
Journal:  ACS Synth Biol       Date:  2012-11-05       Impact factor: 5.110

2.  Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides.

Authors:  Q M Wang; R B Johnson; L N Jungheim; J D Cohen; E C Villarreal
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases.

Authors:  B A Heinz; J Tang; J M Labus; F W Chadwell; S W Kaldor; M Hammond
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli.

Authors:  Q M Wang; R B Johnson; G A Cox; E C Villarreal; L M Churgay; J E Hale
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Application of a Novel CL7/Im7 Affinity System in Purification of Complex and Pharmaceutical Proteins.

Authors:  Louise T Chow; Dmitry G Vassylyev
Journal:  Methods Mol Biol       Date:  2022

6.  Expression and partial purification of recombinant tomato ringspot nepovirus 3C-like proteinase: comparison of the activity of the mature proteinase and the VPg-proteinase precursor.

Authors:  J Chisholm; A Wieczorek; H Sanfaçon
Journal:  Virus Res       Date:  2001-11-05       Impact factor: 3.303

7.  A simple and efficient expression and purification system using two newly constructed vectors.

Authors:  Huanting Liu; James H Naismith
Journal:  Protein Expr Purif       Date:  2008-09-20       Impact factor: 1.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.